Skip to content
Go To Homepage
  • Products
    • Oncology
    • Prenatal
  • Our Technology
    • Technology
    • Publications
  • Careers
    • Working with Us
    • Open Positions
  • News & Media
    • Press Releases
    • Media Coverage
    • Events
    • Social Media
  • About Us
    • Mission, Vision, Values
    • Leadership & Board
    • Company Milestones
  • Contact
abstract pattern of dots and lines

News & Media

Press Releases

March 18, 2025

BillionToOne Celebrates Major Milestone: 1 Million UNITY Tests

Read

Media Coverage

March 5, 2025

Methylation Monitoring Predicts Pan-Cancer Outcomes

Read

Media Coverage

March 4, 2025

Forbes: 2025 Best Startup Employers

Read

Press Releases

March 3, 2025

BillionToOne’s Northstar Response® Validated in New Peer-Reviewed Study, Building on Previous Clinical Research

Read

General Information

February 28, 2025

BillionToOne Study Lays Out Evidence for NIPT Fetal RhD Detection Accuracy

Read

Press Releases

February 27, 2025

BillionToOne’s Pioneering Study Demonstrates 100% Accuracy for Non-Invasive Fetal RhD Detection in US Population

Read

Follow Us

  • LinkedIn
  • Twitter

See Recent Social Posts

Social Posts

Get more news sent directly to your inbox.

Newsletter(Required)
This field is for validation purposes and should be left unchanged.
Go To Homepage

We are ONE team, working
toward ONE goal – to detect
disease ONE molecule at a time.

CAP Accredited College of American Pathologists

  • What We Offer
  • Our Technology
  • Publications
  • Products
  • Explore
  • News & Media
  • Press Releases
  • Media Coverage
  • Events
  • Social Media
  • About Us
  • Careers
  • Patient Portal
  • IT Security Compliance
  • Contact
  • Contact Information
  • Privacy Policy
  • Notice of Privacy Practices
  • Accessibility Statement
  • TERMS OF USE

ACCREDITATIONS UNION CITY: CLIA: 05D2167800 | CAP: 8643216 | MD: 2999 | RI: LCO01527 | PA: 37021 | CA: 00353741 | DC: HFD-OS29

ACCREDITATIONS MENLO PARK: CA: 90008579  | CAP: 9568790

PATENT MARKINGS

© 2025 BillionToOne Inc.
All rights reserved.